Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001477932-15-006848)

Filing Details

Accession Number:: 0001477932-15-006848
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-10 19:16:04
Reporting Period:: 2015-09-08

Filing Date:: 2015-11-10
Accepted Time:: 2015-11-10 19:16:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029125	Sun Biopharma Inc.	SNBP	Pharmaceutical Preparations (2834)	870543922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640416	Michael David Fuhrman	15 South 1200 East Salt Lake UT 84102		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-08	300,561	$0.00	158,175	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Mr. Fuhrman sold $125,000 of the issuer's debt and 300,561 shares of the issuer's common stock for $125,000 pursuant to transactions reported in the issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission ("SEC") on August 13, 2015, Current Report on Form 8-K filed with the SEC on September 11, 2015, and Schedule 14C filed with the SEC on August 7, 2015, among others.